{"resourceType":"ValueSet","id":"2.16.840.1.113762.1.4.1047.376","meta":{"versionId":"17","lastUpdated":"2016-12-27T01:00:03.000-05:00"},"text":{"status":"generated","div":"<div xmlns=\"http://www.w3.org/1999/xhtml\">\n      <h2>Moderate Emetic Risk Cancer MEdicine interferon alfa 2b</h2>\n      <p>This value set includes codes from the following code systems:</p>\n      <ul>\n        <li>Include these codes as defined in \n          <a href=\"http://www.nlm.nih.gov/research/umls/rxnorm\">\n            <code>http://www.nlm.nih.gov/research/umls/rxnorm</code>\n          </a>\n          <table class=\"none\">\n            <tr>\n              <td>\n                <b>Code</b>\n              </td>\n              <td>\n                <b>Display</b>\n              </td>\n            </tr>\n            <tr>\n              <td>5880</td>\n              <td>Interferon Alfa-2b</td>\n              <td/>\n            </tr>\n          </table>\n        </li>\n      </ul>\n    </div>"},"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.376","version":"20161227","name":"Moderate Emetic Risk Cancer MEdicine interferon alfa 2b","status":"active","date":"2016-12-27T01:00:03-05:00","publisher":"Oncology Nursing Society Steward","compose":{"include":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","concept":[{"code":"5880","display":"Interferon Alfa-2b"}]}]}}